Immuron (IMRN) CSO reports holdings and performance rights
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Immuron Ltd Chief Scientific Officer Jerry Kanellos filed an initial ownership report showing his existing equity position. He directly holds 333,000 Ordinary Shares of Immuron.
He also holds Performance Rights over 272,134 underlying Ordinary Shares with a 0.0000 exercise price expiring on June 30, 2029, and additional Performance Rights over 179,664 underlying Ordinary Shares with a 0.0000 exercise price expiring on July 12, 2027. A footnote states these Performance Rights became exercisable as to 217,707 shares on July 23, 2025 and 54,427 shares on October 29, 2025.
Positive
- None.
Negative
- None.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
Kanellos Jerry
Role
Chief Scientific Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Performance Rights | -- | -- | -- |
| holding | Performance Rights | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Performance Rights — 179,664 shares (Direct, null);
Ordinary Shares — 333,000 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Direct Ordinary Shares: 333,000 shares
Performance Rights 2029: 272,134 underlying shares
Performance Rights 2027: 179,664 underlying shares
+3 more
6 metrics
Direct Ordinary Shares
333,000 shares
Directly held Ordinary Shares reported on Form 3
Performance Rights 2029
272,134 underlying shares
Performance Rights, exercise price 0.0000, expire June 30, 2029
Performance Rights 2027
179,664 underlying shares
Performance Rights, exercise price 0.0000, expire July 12, 2027
Exercise price
0.0000 per share
Stated exercise price for reported Performance Rights
Exercisable tranche
217,707 shares
Performance Rights became exercisable on July 23, 2025
Second exercisable tranche
54,427 shares
Performance Rights became exercisable on October 29, 2025
Key Terms
Performance Rights, Ordinary Shares, exercise price, expiration date
4 terms
Performance Rights financial
"The Performance Rights became exercisable as to 217,707 shares on July 23, 2025"
Performance rights are conditional awards that give employees or executives the promise of receiving company shares or cash only if the business meets specific targets or survives for a set period. They work like a bonus you only get when certain goals are hit, so they matter to investors because they can increase the number of shares outstanding (dilution), signal management’s incentives and confidence in future results, and affect per-share earnings and valuation.
exercise price financial
"conversion_or_exercise_price: "0.0000" for the Performance Rights"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: "2029-06-30T00:00:00.000Z" and "2027-07-12T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
What does Immuron (IMRN) Chief Scientific Officer Jerry Kanellos report on this Form 3?
He reports his existing equity holdings in Immuron. The filing shows 333,000 Ordinary Shares held directly plus significant Performance Rights over additional Ordinary Shares, establishing his baseline ownership as an officer.
When do Jerry Kanellos’ Immuron (IMRN) Performance Rights become exercisable?
A footnote states the Performance Rights became exercisable as to 217,707 shares on July 23, 2025 and 54,427 shares on October 29, 2025. These dates indicate when specific tranches of rights could first be exercised.
Does this Immuron (IMRN) Form 3 show any insider buying or selling?
No buy or sell activity is shown; it records holdings only. The transactions are classified as holdings with unknown transaction codes, providing a snapshot of existing ownership rather than new trades.